Jorge Arellano

1.2k total citations
40 papers, 880 citations indexed

About

Jorge Arellano is a scholar working on Oncology, Surgery and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Jorge Arellano has authored 40 papers receiving a total of 880 indexed citations (citations by other indexed papers that have themselves been cited), including 22 papers in Oncology, 18 papers in Surgery and 16 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Jorge Arellano's work include Bone health and treatments (18 papers), Cancer Diagnosis and Treatment (14 papers) and Management of metastatic bone disease (8 papers). Jorge Arellano is often cited by papers focused on Bone health and treatments (18 papers), Cancer Diagnosis and Treatment (14 papers) and Management of metastatic bone disease (8 papers). Jorge Arellano collaborates with scholars based in United States, Switzerland and United Kingdom. Jorge Arellano's co-authors include Yi Qian, Alexander Liede, Andrea Singer, J. Vanderpuye-Orgle, E. Michael Lewiecki, Michael S. Broder, Jesse D. Ortendahl, Andreas Grauer, Guillermo Villa and Gregg C. Fonarow and has published in prestigious journals such as Journal of Clinical Oncology, PLoS ONE and Journal of Affective Disorders.

In The Last Decade

Jorge Arellano

39 papers receiving 864 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Jorge Arellano United States 18 354 277 212 184 107 40 880
Ioannis Kyvernitakis Germany 19 467 1.3× 115 0.4× 81 0.4× 456 2.5× 34 0.3× 70 1.1k
Maria Olsen Netherlands 12 318 0.9× 92 0.3× 112 0.5× 68 0.4× 23 0.2× 20 923
Ogo Egbuna United States 18 371 1.0× 230 0.8× 127 0.6× 322 1.8× 20 0.2× 37 1.3k
Jeroen Mebis Belgium 19 448 1.3× 98 0.4× 261 1.2× 64 0.3× 51 0.5× 65 973
Michael Steinbuch United States 14 288 0.8× 192 0.7× 84 0.4× 171 0.9× 15 0.1× 24 1.3k
Bradley S. Stolshek United States 16 266 0.8× 116 0.4× 24 0.1× 237 1.3× 84 0.8× 44 753
Ros Wade United Kingdom 14 140 0.4× 252 0.9× 50 0.2× 22 0.1× 42 0.4× 36 686
Andrzej Tukiendorf Poland 17 172 0.5× 250 0.9× 163 0.8× 13 0.1× 29 0.3× 119 1.1k
Natalie Boytsov United States 11 182 0.5× 265 1.0× 26 0.1× 283 1.5× 45 0.4× 44 890
Theodore T. Suh United States 14 116 0.3× 73 0.3× 199 0.9× 57 0.3× 66 0.6× 23 1.0k

Countries citing papers authored by Jorge Arellano

Since Specialization
Citations

This map shows the geographic impact of Jorge Arellano's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jorge Arellano with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jorge Arellano more than expected).

Fields of papers citing papers by Jorge Arellano

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jorge Arellano. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jorge Arellano. The network helps show where Jorge Arellano may publish in the future.

Co-authorship network of co-authors of Jorge Arellano

This figure shows the co-authorship network connecting the top 25 collaborators of Jorge Arellano. A scholar is included among the top collaborators of Jorge Arellano based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jorge Arellano. Jorge Arellano is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Qian, Yi, Jorge Arellano, Francesca Gatta, et al.. (2018). Physicians’ preferences for bone metastases treatments in France, Germany and the United Kingdom. BMC Health Services Research. 18(1). 518–518. 6 indexed citations
3.
Hussain, Arif, Candice Yong, Katherine Tkaczuk, et al.. (2018). Prevalence and risk of skeletal complications and use of radiation therapy in elderly women diagnosed with metastatic breast cancer. PLoS ONE. 13(3). e0193661–e0193661. 7 indexed citations
4.
Qian, Yi, Jorge Arellano, Brett Hauber, et al.. (2016). Patient, Caregiver, and Nurse Preferences for Treatments for Bone Metastases from Solid Tumors. Patient. 9(4). 323–333. 12 indexed citations
5.
Liede, Alexander, et al.. (2016). International survey of androgen deprivation therapy (ADT) for non-metastatic prostate cancer in 19 countries. ESMO Open. 1(2). e000040–e000040. 31 indexed citations
6.
Cleeland, Charles S., Roger von Moos, Mark S. Walker, et al.. (2016). Burden of symptoms associated with development of metastatic bone disease in patients with breast cancer. Supportive Care in Cancer. 24(8). 3557–3565. 31 indexed citations
7.
Aly, Ahmad, Eberechukwu Onukwugha, Corinne Woods, et al.. (2015). Measurement of skeletal related events in SEER-Medicare: a comparison of claims-based methods. BMC Medical Research Methodology. 15(1). 65–65. 22 indexed citations
8.
Arellano, Jorge, Brett Hauber, Ateesha F. Mohamed, et al.. (2015). Physicians’ Preferences for Bone Metastases Drug Therapy in the United States. Value in Health. 18(1). 78–83. 22 indexed citations
9.
Stopeck, Alison, Karim Fizazi, Jean-Jacques Body, et al.. (2015). Safety of long-term denosumab therapy: results from the open label extension phase of two phase 3 studies in patients with metastatic breast and prostate cancer. Supportive Care in Cancer. 24(1). 447–455. 136 indexed citations
10.
11.
Hechmati, Guy, Brett Hauber, Jorge Arellano, et al.. (2014). Patients’ preferences for bone metastases treatments in France, Germany and the United Kingdom. Supportive Care in Cancer. 23(1). 21–28. 29 indexed citations
12.
Qian, Yi, et al.. (2014). Short-term disability in solid tumor patients with bone metastases and skeletal-related events. Journal of Medical Economics. 18(3). 210–218. 6 indexed citations
13.
14.
Benedict, Ágnes, et al.. (2009). Economic evaluation of duloxetine versus serotonin selective reuptake inhibitors and venlafaxine XR in treating major depressive disorder in Scotland☆. Journal of Affective Disorders. 120(1-3). 94–104. 24 indexed citations
15.
Jiménez-Balderas, Francisco Javier, et al.. (2001). High frequency of association of rheumatic/autoimmune diseases and untreated male hypogonadism with severe testicular dysfunction. Arthritis Research & Therapy. 3(6). 362–7. 41 indexed citations
16.
17.
Arellano, Jorge, et al.. (2000). Increased Susceptibility to Experimental Amebic Abscess of the Liver (EAAL) in Gerbils (Meriones unguiculatus) with Induced Eosinopenia. Archives of Medical Research. 31(4). S108–S109. 2 indexed citations
18.
Mercado, Moisés, et al.. (1999). Thyrotoxic Periodic Paralysis in Mexican Mestizo Patients. Archives of Medical Research. 30(1). 74–76. 11 indexed citations
19.
Arellano, Jorge, Martha Pérez‐Rodríguez, Juan R. Velázquez, et al.. (1996). Increased frequency of HLA‐DR3 and complotype SCO1 in Mexican mestizo children with amoebic abscess of the liver. Parasite Immunology. 18(10). 491–498. 28 indexed citations
20.
Arellano, Jorge, Martha Isabel Vallejo, Javier León Jiménez, Gregorio Mintz, & R Kretschmer. (1984). HLA‐B27 and ankylosing spondylitis in the Mexican Mestizo population. Tissue Antigens. 23(2). 112–116. 17 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Ioannis Kyvernitakis Breakdown of academic impact, for papers by Maria Olsen Breakdown of academic impact, for papers by Ogo Egbuna Breakdown of academic impact, for papers by Jeroen Mebis Breakdown of academic impact, for papers by Michael Steinbuch Breakdown of academic impact, for papers by Bradley S. Stolshek Breakdown of academic impact, for papers by Ros Wade Breakdown of academic impact, for papers by Andrzej Tukiendorf Breakdown of academic impact, for papers by Natalie Boytsov Breakdown of academic impact, for papers by Theodore T. Suh
Rankless by CCL
2026